+390.6%
LLY vs BBIO
+42.7%
+347.9%
-34.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -0.1% | -0.6% | -0.6% |
| 7D | -2.9% | -3.2% | +0.3% | -2.8% |
| 30D | -8.4% | -13.6% | +5.2% | -7.9% |
| 3M | -3.8% | +7.2% | -11.0% | -4.0% |
| 6M | +11.9% | +1.5% | +10.5% | +11.8% |
| YTD | +4.3% | -5.3% | +9.6% | +4.3% |
| 1Y | +48.5% | +37.7% | +10.7% | +46.7% |
| 3Y | +91.2% | +153.9% | -62.7% | +85.0% |
| All | +390.6% | +42.7% | +347.9% | +337.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling